On this episode of Advances in Care, host Erin Welsh sits down with Dr. Thomas Bottiglieri, chief of the primary care sports medicine division at NewYork-Presbyterian and Columbia, to discuss the evolving landscape of concussion care– from prevalence to emerging diagnostic breakthroughs.

With over 2 million estimated concussions occurring annually in the United States, and many of them affecting young athletes, Dr. Bottiglieri and his colleagues have sought to develop a more accurate and accessible way to objectively diagnose concussion. While a single injury may not cause long term issues, research shows that repeated head trauma– and lack of proper care– can lead to premature neurodegeneration.

During their research to improve diagnostic measures, Dr. Bottiglieri and his team discovered a biomarker associated with severe concussions: a subtle tremor of the head and neck that becomes amplified when a concussed patient tries to visually focus on a target.

This discovery led to the development of ProScope, an innovative eyetracking software tool that measures head and neck stability and can detect the diagnostic biomarker with over 80% sensitivity. With the advent of these tools, clinicians can now, for the first time, objectively measure concussion. A former competitive athlete himself, Dr. Bottiglieri hopes that the ProScope tool can become commercially available to improve access to cost-effective diagnosis, ensuring that athletes– or anyone with a head injury– can recover safely and return to the activities they love.

***

Thomas S. Bottiglieri, D.O. is a sports medicine physician specializing in the management of orthopedic injuries and disorders impacting athletes at all skill levels from adolescents to seniors. In addition to treating the full spectrum of muscle, bone, tendon, and joint injuries, Dr. Bottiglieri is a nationally recognized expert in the field of concussion care. His practice stresses shared decision-making with patients and their families and uses the latest medical technology, evidence-based sports medicine, and a compassionate, patient-centered approach.

For more information visit nyp.org/Advances

On the final episode of 2025, host Erin Welsh is joined by Courtney Allison, host of NewYork-Presbyterian’s health and wellness podcast, Health Matters, to recap the year’s highlights from their dozens of conversations with clinicians, researchers, and health care specialists from Columbia & Weill Cornell Medicine. They highlight key takeaways, revisit groundbreaking treatments that were pioneered across the institution, and discuss several research updates that are shaping the future of medicine for both physicians and patients.

For more information visit nyp.org/Advances

For any patient diagnosed with depression for the first time, the recommended course of treatment is the same: a medication like a selective serotonin reuptake inhibitor (SSRI), an evidence based psychotherapy, or both. But there is a large group of people for whom these treatments simply won't work. That’s where Dr. Conor Liston and his team focus. In this episode from the Advances in Care archives, Dr. Liston speaks with former host Catherine Price about his work mapping the brain is helping doctors better understand where depression is impacting certain brain structures and what that means for the symptoms patients present. Dr. Liston’s work is focused on identifying how these symptoms impact patients' brains and using those findings to identify the best treatment approach.

Since this episode aired, Dr. Liston and his colleagues have continued to build on their research regarding a specific region of the brain called the “salience network.” They found that the salience network was considerably larger in people with clinical depression than in those without, and that people with larger salience networks in childhood were more likely to develop depression later in life. Their research points to an enlarged salience network as the first objective biomarker for diagnosing depression, which could revolutionize how depression is treated, and allow for intervention even before symptoms develop.

In this episode from the Advances in Care archives, Dr. Pierre Elias sits down with Catherine Price to talk about how utilizing technologies like artificial intelligence and machine learning can help diagnose patients even before symptoms develop, and support doctors by freeing them up to focus on providing personalized care to their patients. They discuss navigating bias in both artificial intelligence and clinical care, and how new technology will improve the future of medicine.

Since this episode aired, Dr. Elias and his collaborators expanded their research involving AI and cardiac care, developing tools for detecting mitral regurgitation and heart failure.

Additionally, a team at NewYork-Presbyterian and Columbia used AI as a fertility treatment for azoospermia, and NewYork-Presbyterian deepened its commitment to developing applications of AI in medicine through a $2 billion campaign to invest in talent and technology.

For more information visit nyp.org/Advances

With perspectives spanning hepatobiliary, gynecologic, and cardiac surgeries, NewYork-Presbyterian’s Dr. Jason Hawksworth (Columbia), Dr. Tamatha Fenster (Weill Cornell Medicine), and Dr. Arnar Geirsson (Columbia) describe how they each came to incorporate robotics into their practices. One of the biggest takeaways: robotic surgeries allow for more accuracy in minimally-invasive approaches; so patients experience shorter hospital stays and quicker recoveries, even after major procedures. But there are some limitations to robotic surgeries that the doctors are still navigating. Dr. Fenster discusses how there are haptics limitations in robotic surgery. As a result, she shares more about her innovative smartHER 3D MRI program that is addressing this issue and details how her and her team are developing a way of holographically projecting 3D MRIs over patients to help guide surgeons while they operate.

Since this episode aired, a team at Weill Cornell Medicine performed the first fully robotic liver transplant in the state of New York, and the Robotic Cardiac Surgery Program at NewYork-Presbyterian and Columbia completed over 100 robotic heart surgeries. Additionally, Dr. Tamatha Fenster put smartHER 3D MRI technology into practice.

For more information visit nyp.org/Advances

Catherine Price and Dr. Emile Bacha, Chief of the Division of Cardiac, Thoracic, and Vascular Surgery at NewYork-Presbyterian/Columbia discuss the history of heart surgery, ventricular assist devices, and a new frontier in cardiac surgery: The Total Artificial Heart. Dr. Bacha tells the groundbreaking story of successfully fitting a pediatric patient with a Total Artificial Heart. He explains the nuances of the procedure, and how a backpack-powered heart gave his pediatric patient another chance.

In 2023, Dr. Bacha led a team to complete the first domino infant partial heart transplant in the world. Surgeons in his division also completed the first split-root domino transplant in the northeast, saving the lives of three young patients. Most recently, Dr. Bacha became the 106th president of the American Association for Thoracic Surgery.

For more information visit nyp.org/Advances

Dr. Chris Ahmad knows firsthand how devastating an untimely injury can be for a young athlete. In this episode from the Advances in Care archives, Dr. Ahmad discusses how his own college soccer injury led him to fall in love with orthopedics. He tells the history of the infamous baseball injury that resulted in the invention of Tommy John surgery, and shares how he learned to perform the corrective procedure from the man who designed it. Dr. Ahmad chronicles his endeavors to innovate orthopedic surgery and get athletes back onto the field stronger – both physically and mentally.

Since this episode aired, Dr. Ahmed and his colleagues at NewYork-Presbyterian have taken Tommy John surgery to new heights. They’ve introduced an innovative approach to the procedure called Triple Tommy John Surgery, or TJ3. TJ3 combines ULC repair with reconstruction techniques, offering faster recovery with fewer setbacks and better career longevity for these world class athletes.

For more information visit nyp.org/Advances

On this episode of Advances in Care, we return to the high-intensity environment of New York City’s emergency departments with Dr. Angela Mills and Dr. Brenna Farmer. Host Erin Welsh hears from these leaders at NewYork-Presbyterian about how they are implementing innovative strategies to meet the challenges of the behavioral health emergencies epidemic.

Dr. Brenna Farmer, chief of emergency medicine at NewYork-Presbyterian Brooklyn Methodist, and Dr. Angela Mills, chief of emergency medicine at NewYork-Presbyterian and Columbia, bring us inside the emergency departments they lead to explain the challenges that their staff face in meeting the needs of severely decompensated patients. From disruptions in the flow of care, to potentially violent outbursts, their teams navigate these issues against the backdrop of an already complex operational environment.

Dr. Farmer tells us how she has implemented an innovative protocol called BERT– the Behavioral Health Response Team– in the Brooklyn Methodist Emergency Department, which is rolling out across the NewYork-Presbyterian system. BERT allows ED teams to better address behavioral health patients, leading to more robust support for staff, and quicker, more comprehensive patient care overall, including connecting them to much needed outpatient resources. Finally, Dr. Farmer and Dr. Mills share additional strategies they employ to support their own well-being– and that of their medical teams– as they face difficult cases, plus their personal reasons for working in this unique field.

***

Dr. Angela M. Mills is a nationally recognized leader and expert in emergency medicine. She serves as the inaugural chair of the newly designated Department of Emergency Medicine at Columbia University Irving Medical Center and chief of Emergency Medicine Services at NewYork-Presbyterian.

Dr. Brenna M. Farmer is Chief of Emergency Medicine at NewYork-Presbyterian Brooklyn Methodist Hospital and vice chair for the Department of Emergency Medicine at Weill Cornell Medicine. She is also an assistant associate professor of clinical emergency medicine at Weill Cornell Medicine. Dr. Farmer is a nationally recognized medical toxicology expert and frequent keynote speaker on quality improvement, patient safety, and medication safety.

For more information visit nyp.org/Advances.